Literature DB >> 30527183

Automated detection of lung cancer at ultralow dose PET/CT by deep neural networks - Initial results.

Moritz Schwyzer1, Daniela A Ferraro2, Urs J Muehlematter1, Alessandra Curioni-Fontecedro3, Martin W Huellner2, Gustav K von Schulthess2, Philipp A Kaufmann2, Irene A Burger2, Michael Messerli4.   

Abstract

OBJECTIVES: We evaluated whether machine learning may be helpful for the detection of lung cancer in FDG-PET imaging in the setting of ultralow dose PET scans.
MATERIALS AND METHODS: We studied the performance of an artificial neural network discriminating lung cancer patients (n = 50) from controls (n = 50) without pulmonary malignancies. A total of 3936 PET slices including images in which the lung tumor is visually present and image slices of patients with no lung cancer were exported. The diagnostic performance of the artificial neural network based on clinical standard dose PET images (PET100%) as well as with a tenfold (PET10%) and thirtyfold (PET3.3%) reduced radiation dose (∼0.11 mSv) was assessed.
RESULTS: The area under the curve of the deep learning algorithm for lung cancer detection was 0.989, 0.983 and 0.970 for standard dose images (PET100%), and reduced dose PET10%, and PET3.3% reconstruction, respectively. The artificial neural network achieved a sensitivity of 95.9% and 91.5% and a specificity of 98.1% and 94.2%, at standard dose and ultralow dose PET3.3%, respectively.
CONCLUSION: Our results suggest that machine learning algorithms may aid fully automated lung cancer detection even at very low effective radiation doses of 0.11 mSv. Further improvement of this technology might improve the specificity of lung cancer screening efforts and could lead to new applications of FDG-PET.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artificial intelligence; Deep learning; Low dose; Lung cancer; PET/CT

Mesh:

Year:  2018        PMID: 30527183     DOI: 10.1016/j.lungcan.2018.11.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  21 in total

Review 1.  Physician centred imaging interpretation is dying out - why should I be a nuclear medicine physician?

Authors:  Roland Hustinx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-06-07       Impact factor: 9.236

2.  Artificial intelligence, machine (deep) learning and radio(geno)mics: definitions and nuclear medicine imaging applications.

Authors:  Dimitris Visvikis; Catherine Cheze Le Rest; Vincent Jaouen; Mathieu Hatt
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-06       Impact factor: 9.236

3.  Artificial intelligence in clinical research of cancers.

Authors:  Dan Shao; Yinfei Dai; Nianfeng Li; Xuqing Cao; Wei Zhao; Li Cheng; Zhuqing Rong; Lan Huang; Yan Wang; Jing Zhao
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

4.  A pilot study on lung cancer detection based on regional metabolic activity distribution in digital low-dose 18F-FDG PET.

Authors:  Michael Messerli; Urs J Muehlematter; Saskia Fassbind; Daniel Franzen; Daniela A Ferraro; Martin W Huellner; Valerie Treyer; Alessandra Curioni-Fontecedro; Irene A Burger
Journal:  Br J Radiol       Date:  2021-02-02       Impact factor: 3.039

Review 5.  Artificial Intelligence for Response Evaluation With PET/CT.

Authors:  Lise Wei; Issam El Naqa
Journal:  Semin Nucl Med       Date:  2020-11-11       Impact factor: 4.446

Review 6.  Improving PET Imaging Acquisition and Analysis With Machine Learning: A Narrative Review With Focus on Alzheimer's Disease and Oncology.

Authors:  Ian R Duffy; Amanda J Boyle; Neil Vasdev
Journal:  Mol Imaging       Date:  2019 Jan-Dec       Impact factor: 4.488

7.  Differences among COVID-19, Bronchopneumonia and Atypical Pneumonia in Chest High Resolution Computed Tomography Assessed by Artificial Intelligence Technology.

Authors:  Robert Chrzan; Monika Bociąga-Jasik; Amira Bryll; Anna Grochowska; Tadeusz Popiela
Journal:  J Pers Med       Date:  2021-05-10

Review 8.  Applications of artificial intelligence in oncologic 18F-FDG PET/CT imaging: a systematic review.

Authors:  Mohammad S Sadaghiani; Steven P Rowe; Sara Sheikhbahaei
Journal:  Ann Transl Med       Date:  2021-05

9.  Glycolysis on F-18 FDG PET/CT Is Superior to Amino Acid Metabolism on C-11 Methionine PET/CT in Identifying Advanced Renal Cell Carcinoma at Staging.

Authors:  Suk-Hyun Lee; Jee-Soo Park; Hyunjeong Kim; Dongwoo Kim; Seung-Hwan Lee; Won-Sik Ham; Woong-Kyu Han; Young-Deuk Choi; Mijin Yun
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

Review 10.  Artificial intelligence and hybrid imaging: the best match for personalized medicine in oncology.

Authors:  Martina Sollini; Francesco Bartoli; Andrea Marciano; Roberta Zanca; Riemer H J A Slart; Paola A Erba
Journal:  Eur J Hybrid Imaging       Date:  2020-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.